Intellectual Property Issues in Life Sciences: Disputes and Controversies | Agenda Bookshop Skip to content
Selected Colleen Hoover Books at €9.99c | In-store & Online
Selected Colleen Hoover Books at €9.99c | In-store & Online
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Chetan Keswani
B01=Cristina Possas
Category1=Non-Fiction
Category=LNR
Category=PS
Category=TCB
Category=TVB
COP=United Kingdom
Delivery_Pre-order
Language_English
PA=Not yet available
Price_€100 and above
PS=Forthcoming
softlaunch

Intellectual Property Issues in Life Sciences: Disputes and Controversies

English

Intellectual Property Issues in Life Sciences: Disputes and Controversies highlights emerging legal, social, and regulatory issues pertaining to various areas of life sciences. Patents occupy a prominent position in the innovation systems in the life sciences, but to what extent they support, or hinder innovation is widely disputed. Life science is a broad subject including agriculture, ecology, microbiology, plant and animal sciences, health and diseases, biotechnology, etc. However, despite the broad applications of biotechnology and molecular biology techniques, profits on investments are surprisingly low. Thus, it is vitally important for universities, public research organizations, and private enterprises to protect their innovations. There are vast differences of opinion on patentability of living organisms, which are largely barred from patent protection. However, mind-sets are rapidly shifting and IP issues in life sciences are receiving increasing attention. To compete with progressive bio-based economies the developing countries are amending their IP laws to encourage investment.

An effort has been made to avoid considering policy in isolation, but rather to emphasize the interplay between the policy mix, the wider institutional setting, market forces, and system organization solutions. Both empirical and conceptual chapters are included to bring them together and to yield facts and interpretations for the readers.

This book presents expert opinions by frontier academicians, researchers, and attorneys on the recent challenges in the rapidly evolving life science industry. The present book offers comprehensive knowledge on the contemporary issues in life sciences to a wide range of audiences including students, scholars, researchers, legal practitioners, policymakers, and others interested in emerging intellectual property issues.

Features

  • The only compilation available on the contemporary intellectual property issues in life sciences in the post-COVID era.
  • Focuses on the commercial, regulatory, bioethical, and socio-legal implications of patents in life sciences.
  • Describes an integrated approach for sustained innovations in various areas of life sciences.
  • Discusses the recent IP controversies in a pan-global context.
  • Presents viewpoints to front-line practitioners, viz attorneys, researchers, etc.
See more
Current price €117.79
Original price €123.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Chetan KeswaniB01=Cristina PossasCategory1=Non-FictionCategory=LNRCategory=PSCategory=TCBCategory=TVBCOP=United KingdomDelivery_Pre-orderLanguage_EnglishPA=Not yet availablePrice_€100 and abovePS=Forthcomingsoftlaunch

Will deliver when available. Publication date 15 Nov 2024

Product Details
  • Dimensions: 156 x 234mm
  • Publication Date: 15 Nov 2024
  • Publisher: Taylor & Francis Ltd
  • Publication City/Country: United Kingdom
  • Language: English
  • ISBN13: 9781032522319

About

Dr. Chetan Keswani is the Head of Agro-Biotechnology Laboratory in the Academy of Biology and Biotechnology Southern Federal University Rostov-on-Don Russia. He has a keen interest in regulatory commercialization and intellectual property aspects of agriculturally important microorganisms. He is an elected Fellow of the Linnaean Society of London UK and received Best Ph.D. Thesis Award from the Uttar Pradesh Academy of Agricultural Sciences India in 2015. He is an editorial board member of several reputed agricultural microbiology journals and has edited ten books on the subject. For his editorial endeavors he was awarded the Publons Top Peer Review Award in Agricultural Sciences (2018) Outstanding Editor Award (2019) by Archives of Phytopathology and Plant Protection Taylor and Francis and Springer-Society Award (2020) for Excellent contribution to the journal Environmental Sustainability Springer-Nature. In addition he has been listed among the Worlds Top 2% Scientists for the single year 2022 (Sub-fields: Plant Biology & Botany and Biotechnology). Dr. Cristina Possas is a Full Professor and Researcher at the Oswaldo Cruz Foundation-Fiocruz Rio de Janeiro Brazil. Scientific Advisor for Fiocruz´ President she directed the Advisory Unit for Special Studies for the Presidency. She has been for ten years Director of the Research and Technological Development Unit of the Brazilian National AIDS Program in the Ministry of Health and for two years the Executive Secretary of the National Biosafety Commission CTNBio responsible for evaluation of genetically modified organisms (GMOs) projects nominated by the Brazilian Minister of Science and Technology. She has a post-doctorate in International Health from Harvard University School of Public Health where she stayed for 10 years as a Takemi Fellow Fulbright Fellow and Visiting Scientist at the Harvard New Diseases Group. She coordinated FIOCRUZ Graduate Programs in Public Health and in Clinical Research on Infectious Diseases (Masters Doctoral and Postdoctoral). She developed at Fiocruz her academic activities and research projects at the National School of Public Health and at the Evandro Chagas National Institute of Infectious Diseases-INI in the Laboratory of AIDS Clinical Research-LAPCLIN-AIDS and at Bio-Manguinhos where she is Senior Scientific Advisor and Professor at the Multi-institutional Doctoral Program in Nanobiosystems.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept